Ikarian Capital, LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $14.8 Million - $18 Million	-207,100 Reduced 66.0%	106,700 $8.84 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $15.9 Million - $19.8 Million	213,800 Added 213.8%	313,800 $24.2 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $7.17 Million - $9.15 Million	100,000 New	100,000 $8.84 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $2.71 Million - $4.94 Million	-37,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $3 Million - $4.68 Million	37,700 New	37,700 $4.65 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.